Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression
- PMID: 1543206
- DOI: 10.1016/0002-9343(92)90113-p
Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression
Abstract
A patient with near fatal Strongyloides hyperinfection syndrome is briefly described. Investigation for possible risk factors for this parasitic infection disclosed that he was a carrier of human T-cell leukemia virus type I (HTLV-I), but without evidence of disease due to this retrovirus. Over the next few years, the patient's serum antibody levels of IgG to S. stercoralis larvae declined and became undetectable despite continued infection with the parasite. Repeated courses of appropriate treatment cleared the parasitic infection only temporarily. The patient was also found to have undetectable total serum IgE and a negative immediate hypersensitivity skin test to S. stercoralis antigens. Five of six other patients with HTLV-I-associated disease and with or without strongyloidiasis were also found to have very low total serum IgE levels. It is postulated that HTLV-I infection in certain individuals may selectively impair immune responses that are critical in controlling strongyloidiasis.
Comment in
-
Strongyloides hyperinfection in patients coinfected with HTLV-I and S. stercoralis.Am J Med. 1993 Apr;94(4):447-9. doi: 10.1016/0002-9343(93)90163-j. Am J Med. 1993. PMID: 8475941 Review. No abstract available.
Similar articles
-
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.Clin Exp Immunol. 2002 Feb;127(2):354-9. doi: 10.1046/j.1365-2249.2002.01733.x. Clin Exp Immunol. 2002. PMID: 11876761 Free PMC article.
-
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.J Infect Dis. 1998 Dec;178(6):1856-9. doi: 10.1086/314507. J Infect Dis. 1998. PMID: 9815251
-
Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.Am J Trop Med Hyg. 1997 Jan;56(1):71-5. doi: 10.4269/ajtmh.1997.56.71. Am J Trop Med Hyg. 1997. PMID: 9063365
-
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.Parasite Immunol. 2004 Nov-Dec;26(11-12):487-97. doi: 10.1111/j.0141-9838.2004.00726.x. Parasite Immunol. 2004. PMID: 15771684 Review.
-
[Combined infection with HTLV-1 and Strongyloides stercoralis].Bull Soc Pathol Exot. 2011 Aug;104(3):188-99. doi: 10.1007/s13149-011-0175-z. Epub 2011 Jul 28. Bull Soc Pathol Exot. 2011. PMID: 21800110 Review. French.
Cited by
-
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.Clin Exp Immunol. 2002 Feb;127(2):354-9. doi: 10.1046/j.1365-2249.2002.01733.x. Clin Exp Immunol. 2002. PMID: 11876761 Free PMC article.
-
Strongyloides stercoralis in the Immunocompromised Population.Clin Microbiol Rev. 2004 Jan;17(1):208-17. doi: 10.1128/CMR.17.1.208-217.2004. Clin Microbiol Rev. 2004. PMID: 14726461 Free PMC article. Review.
-
Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.Rev Soc Bras Med Trop. 2021 May 17;54(suppl 1):e2020605. doi: 10.1590/0037-8682-605-2020. eCollection 2021. Rev Soc Bras Med Trop. 2021. PMID: 34008723 Free PMC article.
-
Dysregulation of strongyloidiasis: a new hypothesis.Clin Microbiol Rev. 1992 Oct;5(4):345-55. doi: 10.1128/CMR.5.4.345. Clin Microbiol Rev. 1992. PMID: 1423214 Free PMC article. Review.
-
DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.Infect Immun. 2005 Apr;73(4):2298-305. doi: 10.1128/IAI.73.4.2298-2305.2005. Infect Immun. 2005. PMID: 15784574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical